Lack of association between erythropoietin treatment and risk of depression in patients with end-stage kidney disease on maintenance dialysis: a nationwide database study in Taiwan.
Pao-Yen LinLung-Chih LiLiang-Jen WangYao-Hsu YangChih-Wei HsuPublished in: Therapeutic advances in chronic disease (2021)
In summary, using the nationwide reimbursement data in Taiwan, we found that EPO treatment in ESKD patients was not associated with their general risk of developing depression.